Long-term multidrug- and rifampicin-resistant tuberculosis treatment outcome by new WHO definitions in Germany
Ralf Otto-Knapp, Brit Häcker, David Krieger, Katarina Stete, Katharina Starzacher, Christina Maier, Jan Heyckendorf, Korkut Avsar, Isabelle Suárez, Jan Rybniker, Torsten Bauer, Gunar Günther, Christoph Lange
Source: Eur Respir J, 60 (5) 2200765; 10.1183/13993003.00765-2022
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ralf Otto-Knapp, Brit Häcker, David Krieger, Katarina Stete, Katharina Starzacher, Christina Maier, Jan Heyckendorf, Korkut Avsar, Isabelle Suárez, Jan Rybniker, Torsten Bauer, Gunar Günther, Christoph Lange. Long-term multidrug- and rifampicin-resistant tuberculosis treatment outcome by new WHO definitions in Germany. Eur Respir J, 60 (5) 2200765; 10.1183/13993003.00765-2022
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|